glp-1 news september 26 2025 medications like Ozempic, Wegovy and Mounjaro are changing diabetes and weight management, but they aren't recommended during pregnancy or while nursing. The current recommendation is to stop before conception and discuss ISPOR 2025: Exploring reasons for

[2] Since then, several other GLP-1 agonists have been developed and approved for clinical use, including liraglutide (Victoza), dulaglutide (Trulicity), semaglutide (Ozempic and Wegovy), and Tirzepatide (Mounjaro and Zepbound)

When this happens, it stimulates insulin and lowers glucagon, both of which have the effect of lowering your blood sugar

The Root-Cause Approach to Healing with Dr

201501034414 (1159734-U) Copyright 1994-2026 All Rights Reserved

She was initially started on liraglutide with limited weight response

Ophthalmic complications The ELIXA, EXSCEL, HARMONY outcomes and PIONEER-6 trials did not include retinopathy as an outcome